Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Clinical Science (London, England : 1979)|September 1, 1993
Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosisR M Borzì, B Grigolo, R Meliconi, et al.Allergologia Et Immunopathologia|March 1, 1991
Antibodies to hepatocyte derived antigens and liver damage in patients after bone marrow transplantationR M Borzì, R Meliconi, R Conte, et al.Scientific Reports|September 23, 2017
Glycogen Synthase Kinase-3β Inhibition Links Mitochondrial Dysfunction, Extracellular Matrix Remodelling and Terminal Differentiation in ChondrocytesS Guidotti, M Minguzzi, D Platano, et al.Clinical and Experimental Immunology|December 9, 1998
Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosisB Grigolo, I Mazzetti, R M Borzì, et al.Journal of Immunological Methods|June 21, 1996
A fluorescent in situ hybridization method in flow cytometry to detect HIV-1 specific RNAR M Borzì, A Piacentini, M C Monaco, et al.Amino Acids|June 21, 2007
Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cellsF Flamigni, I Stanic', A Facchini, et al.Osteoarthritis and Cartilage|April 14, 2016
PKCε is a regulator of hypertrophic differentiation of chondrocytes in osteoarthritisV Queirolo, D Galli, E Masselli, et al.Arthritis and Rheumatism|December 31, 1998
Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritisC Melchiorri, R Meliconi, L Frizziero, et al.Thorax|July 1, 1990
Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?R Meliconi, E Lalli, R M Borzì, et al.Clinical Rheumatology|September 1, 1993
Antibodies to topoisomerase II in idiopathic pulmonary fibrosisR Meliconi, C Negri, R M Borzì, et al.Pageof 3